The Emerging Role of Molecular Testing in an Era of Precision Medicine - Ovarian Cancer

An online panel discussion with leading experts knowledgeable about the importance of utilizing molecular testing in the diagnosis of cancer patients, including issues and perspectives from various stakeholders on molecular testing and next-generation sequencing. The education will also include individual patient-focused cases, which will give clinicians in oncology an opportunity to put into practice what they have learned and to further enhance their subject matter understanding, as well as to allow them to interact directly with clinical content experts.

This activity is supported by an educational grant from AstraZeneca

Faculty

Patrick Kiel, PharmD (Moderator)
Indiana University, Indianapolis, IN

Faculty

Jeanne Schilder, MD
Indiana University, Indianapolis, IN

Faculty

Courtney Cortez, NP
Indiana University, Indianapolis, IN

Faculty

Cynthia Hunter, MS, CGC
Indiana University, Indianapolis, IN

 

The Emerging Role of Molecular Testing in an Era of Precision Medicine - Ovarian Cancer

Patrick Kiel, PharmD
Indiana University, Indianapolis, IN

Posted: 10/12/2017
Expires: 10/12/2018

Credits/Contact Hours: 1.0

Access the Activity for Credit*
   
Participate Without Claiming Credit

* This link will take you to the
Educational Measures website.

This CE/CME/CEU accredited program is jointly provided by

           



Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here